Clinical Trial

Optimal Mammography View Sequencing in Women With a History of Breast Cancer Undergoing Surveillance Mammography

Study acronym: MammoView
Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, single-centre, parallel-group randomised controlled trial evaluates the optimal sequencing of mammography views in women with a history of breast cancer undergoing surveillance mammography. Women treated with breast-conserving surgery within the previous five years will be randomised 1:1:1:1 to one of four mammography view sequencing groups. The primary objective is to compare patient-reported pain and satisfaction across sequencing groups. Secondary objectives include comparison of image quality (PGMI scoring), compression force, and breast thickness. A total of 400 participants will be enrolled at Beaumont Hospital Breast Care Centre over 2.5 years.
Trial Details
NCT Number NCT07443579
Lead Sponsor Royal College of Surgeons, Ireland
Conditions Breast Cancer, Breast Cancer Recurrence, Post Treatment Surveillance
Enrollment 400 participants
Start Date 2026-02-24
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-02